[go: up one dir, main page]

MX2022001601A - Composicion farmaceutica que contiene un agente antifungico como ingrediente activo. - Google Patents

Composicion farmaceutica que contiene un agente antifungico como ingrediente activo.

Info

Publication number
MX2022001601A
MX2022001601A MX2022001601A MX2022001601A MX2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
active ingredient
luliconazole
composition containing
antifungal agent
Prior art date
Application number
MX2022001601A
Other languages
English (en)
Inventor
Masahiro Ito
Kiyotaka Matsui
Masami Inuma
Original Assignee
Sato Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sato Pharma filed Critical Sato Pharma
Publication of MX2022001601A publication Critical patent/MX2022001601A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención proporciona una técnica que permite que una composición farmacéutica, preferiblemente para uso externo, que contiene luliconazol o similar, contenga luliconazol o similar en una alta concentración, y suprime la precipitación del mismo con el tiempo. La presente invención usa un polietilenglicol que tiene un peso molecular promedio de 380 a 420 representado por una fórmula HOCH2(CH2OCH2)nCH2OH (donde n es un número entero), etanol, alcohol bencílico, ácido láctico, carbonato de propileno y acetona en combinación con el luliconazol o similares.
MX2022001601A 2019-08-13 2020-08-07 Composicion farmaceutica que contiene un agente antifungico como ingrediente activo. MX2022001601A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019148620 2019-08-13
PCT/JP2020/030350 WO2021029350A1 (ja) 2019-08-13 2020-08-07 抗真菌薬を有効成分とする医薬組成物

Publications (1)

Publication Number Publication Date
MX2022001601A true MX2022001601A (es) 2022-03-11

Family

ID=74190800

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022001601A MX2022001601A (es) 2019-08-13 2020-08-07 Composicion farmaceutica que contiene un agente antifungico como ingrediente activo.

Country Status (14)

Country Link
US (2) US10898470B1 (es)
EP (1) EP4015042A4 (es)
JP (1) JP6888180B1 (es)
KR (1) KR102871600B1 (es)
CN (1) CN114206387A (es)
AU (1) AU2020327775B2 (es)
BR (1) BR112022002269A2 (es)
CA (1) CA3149802C (es)
CL (1) CL2022000330A1 (es)
MX (1) MX2022001601A (es)
MY (1) MY207505A (es)
PH (1) PH12022550352A1 (es)
TW (1) TWI857116B (es)
WO (1) WO2021029350A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
JP2022109483A (ja) * 2021-01-15 2022-07-28 佐藤製薬株式会社 抗真菌薬を有効成分とする医薬組成物
EP4359635A4 (en) 2021-06-25 2025-03-19 Services Pétroliers Schlumberger CUTTING TOOLS AND CONTROLS FOR MECHANICAL BOREHOLE SERVICES
US20250332120A1 (en) * 2022-07-28 2025-10-30 Kao Corporation Composition for external preparation

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5345937B2 (es) 1974-04-26 1978-12-09
JPS5412723A (en) 1977-06-29 1979-01-30 Bodysonic Kk Attentant feeling reproducing unit
US4162470A (en) 1977-07-26 1979-07-24 Rca Corporation Magnetizing apparatus and method for producing a statically converged cathode ray tube and product thereof
JPS5496659A (en) 1978-01-17 1979-07-31 Nissan Motor Co Ltd Automatic transmission gear
JPS54119654A (en) 1978-03-08 1979-09-17 Daikou Tetsukou Kk Method of producing cylindrical fuse
JPS5938497B2 (ja) 1980-02-25 1984-09-17 日立プラント建設株式会社 風量制御装置
JPH06211651A (ja) 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
JP3803393B2 (ja) 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
WO1996011710A1 (en) 1994-10-13 1996-04-25 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
ZA965745B (en) 1995-07-08 1997-01-27 Nihon Hohyaku Co Ltd Antifungal agent compound therefor process for producing the same and method for using the same
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
JP4253047B2 (ja) 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
US8058303B2 (en) 2006-03-08 2011-11-15 Nihon Nohyaku Co, Ltd Pharmaceutical composition for external use
AU2006339842B2 (en) 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US20100173965A1 (en) 2007-09-05 2010-07-08 Pola Pharma Inc. Antifungal composition
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
JP5453093B2 (ja) 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
CN102395274B (zh) 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
WO2010117089A2 (en) * 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011155640A1 (en) 2010-06-11 2011-12-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
RU2621615C2 (ru) 2012-09-14 2017-06-06 Пола Фарма Инк. Фармацевтическая композиция, содержащая луликоназол
JP2014114249A (ja) 2012-12-11 2014-06-26 Kanae Technos:Kk 基剤、及び皮膚外用剤
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient

Also Published As

Publication number Publication date
US10898470B1 (en) 2021-01-26
KR20220035954A (ko) 2022-03-22
US20210046052A1 (en) 2021-02-18
JP6888180B1 (ja) 2021-06-16
CA3149802C (en) 2024-10-15
TW202114661A (zh) 2021-04-16
TWI857116B (zh) 2024-10-01
CL2022000330A1 (es) 2022-10-21
EP4015042A4 (en) 2023-06-07
EP4015042A1 (en) 2022-06-22
US11738006B2 (en) 2023-08-29
AU2020327775A1 (en) 2022-03-10
CA3149802A1 (en) 2021-02-18
WO2021029350A1 (ja) 2021-02-18
CN114206387A (zh) 2022-03-18
MY207505A (en) 2025-02-28
NZ785310A (en) 2024-05-31
KR102871600B1 (ko) 2025-10-15
US20210220338A1 (en) 2021-07-22
AU2020327775B2 (en) 2023-06-08
JPWO2021029350A1 (ja) 2021-09-13
BR112022002269A2 (pt) 2022-04-19
PH12022550352A1 (en) 2022-12-19

Similar Documents

Publication Publication Date Title
CL2022000330A1 (es) Composición farmacéutica que contiene un agente antifúngico como ingrediente activo
CL2020002252A1 (es) Formulación oftálmica.
AR088383A1 (es) Formulaciones de etanercept estabilizadas con combinaciones de azucares y polioles
NI201700073A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
MX2020005942A (es) Delgada pelicula oral con alta carga de agente activo.
MX392837B (es) Composiciones acidas de limpieza, sanitizacion y desinfeccion con nebulizacion reducida a traves del uso de polimeros de emulsion de agua en aceite de alto peso molecular.
ES2543957T3 (es) Nueva composición farmacéutica para el tratamiento de infecciones fúngicas
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
MX2019014104A (es) Compuesto novedoso de bifenilo o sal del mismo.
AR057697A1 (es) Composiciones de pulverizacion
AR114325A1 (es) Péptidos de la cadena b de la relaxina lipidados modificados y su uso terapéutico
BR112015017246A2 (pt) formulação farmacêutica que compreende um corticosteroide insolúvel e um corticosteroide solúvel
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch
MX385269B (es) Compuesto de sulfonamida o sal del mismo.
MX385380B (es) Formulacion topica para promover la curacion de heridas.
DOP2013000003A (es) Un nuevo conjugado de granulocito colonia-estimulante factor (g-csf) con polietileno glicol
CL2021001636A1 (es) Composición farmacéutica para el tratamiento de la hipertensión arterial pulmonar
AR108037A1 (es) Uso de ésteres de un poliol alcoxilado para preparar una composición adyuvante para reducir la deriva en una formulación agroquímica, composición adyuvante obtenida, uso de la misma para preparar una formulación agroquímica y una mezcla de espray, y dicha formulación agroquímica y mezcla de espray
AR114323A1 (es) Péptidos de la cadena b de la relaxina modificados y su uso terapéutico
AR054729A1 (es) Sistema de administracion
BR112015015202A2 (pt) composição
MX2021000771A (es) Formulacion aerosolizable.
MX382396B (es) Glucono delta-lactona para el tratamiento de infecciones fúngicas vaginales.
MX2020008699A (es) Gotas para los ojos en forma de solucion que comprende un derivado de benzopirano o una sal farmaceuticamente aceptable del mismo.
CO2022004316A2 (es) Formulación de insecticidas que comprenden solventes de glicol éter